Cambridge Massachusetts based Fog Pharmaceuticals is raising $107,000,017.00 in New Equity Investment.
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Fog Pharmaceuticals is raising $107,000,017.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Gregory Verdine played a…